fosaprepitant (Emend)
Jump to navigation
Jump to search
Indications
Dosage
150 mg weekly IV infusion[2]
Mechanism of action
- prodrug of aprepitant
Notes
Manufacturer: Merk
More general terms
Additional terms
References
- ↑ Prescriber's Letter 16(2): 2009 New Drugs Approved by the FDA in 2008 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250213&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 2.0 2.1 Yang Q, Zou X, Xie YL et al Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting. A Pilot Randomized Clinical Trial. JAMA Netw Open. 2023;6(7):e2326127. July 27 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37498596 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807658